SCHEMBL597490

SCHEMBL597490

C#Cc1ccc(OC(C)=O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.57
MAPT P10636 3/20 0.52
POLB P06746 1/20 0.52
PKM P14618 1/20 0.52
ELANE P08246 2/20 0.50
HSD17B10 Q99714 1/20 0.48
GAA P10253 2/20 0.47
ALDH1A1 P00352 1/20 0.47
HSP90AA1 P07900 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 2/20 0.46
CYP3A4 P08684 2/20 0.46
TTR P02766 1/20 0.46
TP53 P04637 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
GLA P06280 1/20 0.44
ESR1 P03372 1/20 0.43
PGR P06401 1/20 0.43
CHRM2 P08172 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16327448 0.83 LMNA (0.61) LMNAMAPTPOLBPKMELANE
SCHEMBL14775396 0.83 KMT2A (0.45) LMNAELANEMEN1KMT2ASMN1; SMN2
SCHEMBL23185543 0.82 ELANE (0.59) LMNAMAPTPOLBPKMELANE
SCHEMBL269329 0.82 LMNA (0.80) LMNAMAPTPOLBPKMELANE
SCHEMBL489581 0.81 LMNA (0.59) LMNAMAPTPOLBPKMELANE
SCHEMBL13867888 0.79 BACE1 (0.54) LMNAMAPTPOLBPKMHSD17B10
Lithium SCHEMBL30522746 0.79 LMNA (0.76) LMNAMAPTPOLBPKMELANE
SCHEMBL14760365 0.79 LMNA (0.76) LMNAMAPTPOLBPKMELANE
SCHEMBL337646 0.79 LMNA (0.57) LMNAMAPTPOLBPKMELANE
SCHEMBL21045001 0.79 CYP19A1 (0.42) LMNAMAPTPOLBPKMELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024025604-A9 DEVELOPMENT OF AN ENZYME-INHIBITOR REACTION USING CELLULAR RETINOIC ACID BINDING PROTEIN II FOR ONE-POT MEGAMOLECULE ASSEMBLY NORTHWESTERN UNIVERSITY (US) 2024-05-02 WO claimed
WO-2024025604-A2 DEVELOPMENT OF AN ENZYME-INHIBITOR REACTION USING CELLULAR RETINOIC ACID BINDING PROTEIN II FOR ONE-POT MEGAMOLECULE ASSEMBLY NORTHWESTERN UNIVERSITY (US) 2024-02-01 WO claimed
CN-116396313-A Alkenyl borate, and preparation method and application thereof 中山大学 2023-07-07 CN claimed
EP-0590557-B1 Process for preparing acetoxystyrene BASF AG (DE) 1996-08-14 EP claimed
US-20250326723-A1 Development of an Enzyme-Inhibitor Reaction Using Cellular Retinoic Acid Binding Protein II for One-Pot Megamolecule Assembly UNIV NORTHWESTERN (US) 2025-10-23 US disclosed
US-12411409-B2 Aromatic underlayer ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2025-09-09 US disclosed
US-12379660-B2 Adhesion promoting photoresist underlayer composition DUPONT ELECTRONIC MATERIALS INTERNATIONAL, LLC (US) 2025-08-05 US disclosed
US-12099300-B2 Aromatic underlayer ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2024-09-24 US disclosed
WO-2024025604-A9 DEVELOPMENT OF AN ENZYME-INHIBITOR REACTION USING CELLULAR RETINOIC ACID BINDING PROTEIN II FOR ONE-POT MEGAMOLECULE ASSEMBLY NORTHWESTERN UNIVERSITY (US) 2024-05-02 WO disclosed
US-11940732-B2 Coating compositions and methods of forming electronic devices ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2024-03-26 US disclosed
CN-114009768-B Daylily probiotic fermented powder, preparation method and fermented daylily solid beverage thereof 中国农业大学 2024-03-08 CN disclosed
WO-2024025604-A2 DEVELOPMENT OF AN ENZYME-INHIBITOR REACTION USING CELLULAR RETINOIC ACID BINDING PROTEIN II FOR ONE-POT MEGAMOLECULE ASSEMBLY NORTHWESTERN UNIVERSITY (US) 2024-02-01 WO disclosed
EP-2099755-A2 ACETYLENE DERIVATIVES AS STEAROYL COA DESATURASE INHIBITORS Glenmark Pharmaceuticals S.A. (CH) 2009-09-16 EP disclosed
US-20090099147-A1 NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS BAYER SCHERING PHARMA AG (DE) 2009-04-16 US disclosed
CN-100448914-C Liquid crystalline thermosets from ester, ester-imide and ester-amide oligomers NASA (US) 2009-01-07 CN disclosed
US-20080182851-A1 ACETYLENE DERIVATIVES AS STEAROYL COA DESATURASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2008-07-31 US disclosed
US-20080166299-A1 Prevent accumulation of amyloid deposits TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2008-07-10 US disclosed
US-20080166299-A1 Prevent accumulation of amyloid deposits TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2008-07-10 US disclosed
WO-2008062276-A2 ACETYLENE DERIVATIVES AS STEAROYL COA DESATURASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (US) 2008-05-29 WO disclosed
CN-1455792-A Liquid crystalline thermosets from ester, ester-imide and ester-amide oligomers NASA (US) 2003-11-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099147-A1 NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS PGR, PGRMC1, PGRMC2 LMNA 2081/4885MAPT 4871/4885POLB 3120/4885
US-20080166299-A1 Prevent accumulation of amyloid deposits APP, IAPP, TTR LMNA 702/4885MAPT 11/4885POLB 3985/4885
US-20080182851-A1 ACETYLENE DERIVATIVES AS STEAROYL COA DESATURASE INHIBITORS SCD, SCD5, ACACA LMNA 823/4885MAPT 2813/4885POLB 3269/4885
US-20250326723-A1 Development of an Enzyme-Inhibitor Reaction Using Cellular Retinoic Acid Binding Protein II for One-Pot Megamolecule Assembly CRABP2, RARB, RARA LMNA 4792/4885MAPT 3789/4885POLB 2560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.